The University of Chicago Header Logo

Connection

Koen Van Besien to Doxorubicin

Back to Details
This is a "connection" page, showing publications Koen Van Besien has written about Doxorubicin.
Koen Van Besien
Connection Strength
0.066
Doxorubicin
  1. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL. Blood. 2023 05 04; 141(18):2194-2205.
    View in: PubMed
    Score: 0.050
  2. Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804. Ann Oncol. 2007 Jun; 18(6):1071-9.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.